Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)
Integrase (IN), an essential enzyme of human immunodeficiency virus (HIV), is an attractive antiretroviral drug target. The antiviral activity and resistance profile in vitro of a novel IN inhibitor, elvitegravir (EVG) (also known as JTK-303/GS-9137), currently being developed for the treatment of H...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | английский |
Опубликовано: |
2007
|
Online-ссылка: | https://doi.org/10.1128/jvi.01534-07 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|